liveBook · Manning

PAINS

As explained in Build AI Drug Discovery Pipelines

A PAINS compound is a pan-assay interference compound whose structure is associated with nonspecific or misleading activity in biological assays.

PAINS (pan-assay interference compounds) are molecules that appear active across diverse high-throughput screens but often produce false-positive results through nonspecific binding or interference with assay readouts. PAINS filters identify associated substructures during early compound-library triage. section 2.3.2

A practical PAINS-filtering workflow:

  • Combine PAINS filtering with other substructure filters, such as BRENK, rather than treating one alert as conclusive evidence of biological behavior. section 2.3.2

Library triage

Applying combined PAINS/BRENK filters to 199,640 compounds flagged 94,010 and retained 105,630, or 52.9% of the library.

How Build AI Drug Discovery Pipelines covers it

How deep it goes
Defines nonspecific assay interference and demonstrates RDKit filtering, but does not explain individual PAINS mechanisms.
Examples
Demonstrates combined PAINS/BRENK filtering on a 199,640-compound library and reports a 52.9% passing rate.
What it assumes
Assumes molecular structures in an RDKit-compatible dataframe and introduces PAINS terminology before applying the filter.
What you can do after
Apply PAINS and BRENK catalogs with RDKit to annotate and filter a compound dataframe.
How it connects
Connects PAINS with high-throughput screening, false positives, nonspecific binding, assay interference, BRENK filters, and structural alerts.

This explainer was generated by Manning's knowledge graph from the text of Build AI Drug Discovery Pipelines. The section links point to the parts of the book it draws on.